HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116 | -99.1% | 1 | -99.2% | 0.00% | – |
| Q2 2023 | $13,371 | -30.8% | 130 | -26.6% | 0.00% | – |
| Q1 2023 | $19,318 | -32.4% | 177 | -29.5% | 0.00% | – |
| Q4 2022 | $28,564 | -1.5% | 251 | -46.3% | 0.00% | – |
| Q3 2022 | $29,000 | -67.4% | 467 | -58.3% | 0.00% | -100.0% |
| Q2 2022 | $89,000 | -23.9% | 1,119 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $117,000 | 0.0% | 1,112 | +2.4% | 0.00% | 0.0% |
| Q4 2021 | $117,000 | -1.7% | 1,086 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $119,000 | +116.4% | 1,086 | +86.3% | 0.00% | 0.0% |
| Q2 2021 | $55,000 | +66.7% | 583 | +62.8% | 0.00% | – |
| Q1 2021 | $33,000 | +22.2% | 358 | -3.5% | 0.00% | – |
| Q4 2020 | $27,000 | +17.4% | 371 | +24.1% | 0.00% | – |
| Q3 2020 | $23,000 | 0.0% | 299 | -29.0% | 0.00% | – |
| Q2 2020 | $23,000 | -93.5% | 421 | -96.5% | 0.00% | -100.0% |
| Q1 2020 | $352,000 | -20.7% | 11,889 | -3.1% | 0.01% | 0.0% |
| Q4 2019 | $444,000 | +32.9% | 12,268 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $334,000 | -7.2% | 12,268 | -18.1% | 0.01% | -16.7% |
| Q2 2019 | $360,000 | – | 14,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |